electroCore

ECOR

Market cap $72.3M

ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort & Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.

electroCore NASDAQ: ECOR Interim President and CFO Joshua Lev said the bioelectronic technology company is focused on expanding its non-invasive vagus nerve stimulation platform across federal health care, commercial insurance channels and consumer wellness markets.

ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical findings in JAMA Network Open titled, “Transcutaneous Electrical Nerve Stimulation and Pain With Movement in People With Fibromyalgia: A Cluster Randomized Clinical Trial.

ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the LD Micro Invitational XVI Conference being held at the Luxe Sunset Boulevard hotel in Los Angeles, CA.   Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.

electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript

electroCore, Inc. (ECOR) came out with a quarterly loss of $0.59 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.47 per share a year ago.

First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year period to $2.3 million Company to host a conference call and webcast today, May 6, 2026, at 4:30 pm EDT ROCKAWAY, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced financial results for the first quarter ended March 31, 2026.

LONDON, April 30, 2026 (GLOBE NEWSWIRE) -- Ecora Royalties PLC (LSE/TSX: ECOR, OTCQX: ECRAF), the London based critical minerals focused royalty and streaming company, announces that Geoff Callow, Head of Investor Relations, will present live at the Precious Metals & Critical Minerals Virtual Investor Conference hosted by VirtualInvestorConferences.com, on May 6th, 2026. DATE: May 6th     TIME: 10 – 10:30am ET REGISTER HERE Available for 1x1 meetings: May 6th.

ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the first quarter ended March 31, 2026, after the close of the market on Wednesday, May 6, 2026.

ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the Market Movers Investor Summit at the historic Bank of New York. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.